Mellanox Technologies, a supplier of high-performance, end-to-end smart interconnect solutions for data centre servers and storage systems, has announced that the company’s InfiniBand and Ethernet solutions have been chosen to accelerate the new NVIDIA DGX-2 artificial intelligence (AI) system
Mellanox Technologies has announced the general availability of its MetroX TX6100 solution that enables InfiniBand and Ethernet RDMA connectivity between data centres
Mellanox Technologies has stated that its end-to-end, FDR 56Gb/s InfiniBand interconnect solutions provide industry-leading performance for compute demanding applications running over the new Intel Xeon processor E5-2600 v2 product family
Mellanox Technologies, a supplier of interconnect solutions for data centre servers and storage systems, has announced the availability of the Mellanox Virtual Modular Switch (VMS) solution, an Ethernet data centre aggregation switch infrastructure
Mellanox Technologies has announced its end-to-end 56 gigabit ethernet product line
Mellanox Technologies has introduced its SwitchX-2 based SX1012 Ethernet switch, a cost-effective solution for small-scale high-performance computing, storage and database deployments
Mellanox Technologies has announced the industry's first network adapter IC and card with hardware offload engines that support virtualised overlay networks commonly used in cloud infrastructures
Mellanox Technologies has announced that its FDR 56Gb/s InfiniBand adapters and switches accelerate Microsoft's new SQL Server 2012 Parallel Data Warehouse appliance
Mellanox Technologies has launched the 'Generation of Open Ethernet' initiative, an alternative approach to traditional closed-code Ethernet switches
Mellanox Technologies, a supplier of high-performance, end-to-end interconnect solutions for data centre servers and storage systems, has announced the availability of new RDMA InfiniBand and Ethernet long-haul interconnect solutions
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.
Cloud research tools provide a platform for new avenues of scientific research by providing fast access to bare-metal resources.
New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.
Tate Cantrell, CTO, Verne Global, comments on the cost of the AI computing revolution
European researchers are working on a new programming environment for exascale computing that aims to make using these systems more efficient and programmers more productive.
